| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.56 | 0.06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |